Joel Thompson

1.2k total citations
33 papers, 877 citations indexed

About

Joel Thompson is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joel Thompson has authored 33 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joel Thompson's work include Pancreatitis Pathology and Treatment (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Joel Thompson is often cited by papers focused on Pancreatitis Pathology and Treatment (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Joel Thompson collaborates with scholars based in United States, Canada and Germany. Joel Thompson's co-authors include Lisa R. Tannock, Patricia G. Wilson, Victoria King, Nancy R. Webb, Frederick C. de Beer, Robin K. Cameron, Catharine Whiteside, Preetha Shridas, Ailing Ji and Jennifer Thompson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Hypertension.

In The Last Decade

Joel Thompson

29 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Thompson United States 16 366 248 153 133 131 33 877
Hiroyuki Kaneto Japan 15 589 1.6× 263 1.1× 161 1.1× 279 2.1× 76 0.6× 47 1.4k
Karen Bulmer United Kingdom 11 478 1.3× 155 0.6× 190 1.2× 59 0.4× 78 0.6× 12 1.1k
Dorella Del Prete Italy 21 495 1.4× 169 0.7× 124 0.8× 452 3.4× 73 0.6× 64 1.3k
Maria Kolatsi‐Joannou United Kingdom 20 731 2.0× 359 1.4× 113 0.7× 248 1.9× 155 1.2× 28 1.4k
Hiroshi Osawa Japan 19 241 0.7× 205 0.8× 154 1.0× 212 1.6× 38 0.3× 120 1.2k
Jun Morinaga Japan 19 374 1.0× 124 0.5× 307 2.0× 118 0.9× 144 1.1× 63 995
Kumiko Torisu Japan 14 302 0.8× 97 0.4× 102 0.7× 197 1.5× 53 0.4× 44 837
Xue Hong China 17 468 1.3× 129 0.5× 158 1.0× 343 2.6× 58 0.4× 31 973
Yuji Aoki Japan 17 359 1.0× 236 1.0× 82 0.5× 54 0.4× 101 0.8× 57 909
Samuel Mon-Wei Yu United States 15 357 1.0× 172 0.7× 86 0.6× 210 1.6× 72 0.5× 34 830

Countries citing papers authored by Joel Thompson

Since Specialization
Citations

This map shows the geographic impact of Joel Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Thompson more than expected).

Fields of papers citing papers by Joel Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Thompson. The network helps show where Joel Thompson may publish in the future.

Co-authorship network of co-authors of Joel Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Thompson. A scholar is included among the top collaborators of Joel Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Thompson. Joel Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shearer, Stuart, Tyler W. Benson, Deborah A. Howatt, et al.. (2025). Attenuation of Atherosclerosis With PAR4 Deficiency: A Potential Role of Hematopoietically Expressed PAR4 in Atherosclerosis—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 45(6). 901–909.
2.
Robinson, Paula D., Lillian Sung, L. Lee Dupuis, et al.. (2024). Outcomes of chemotherapy-induced nausea and vomiting guideline adherence in pediatric and adult patients: a systematic review. Supportive Care in Cancer. 32(7). 455–455. 1 indexed citations
3.
Slade, Emily, Philip A. Kern, Joel Thompson, et al.. (2023). Collaborative team dynamics and scholarly outcomes of multidisciplinary research teams: A mixed-methods approach. Journal of Clinical and Translational Science. 7(1). e59–e59. 6 indexed citations
4.
Elgarten, Caitlin W., John A. Kairalla, Joel Thompson, et al.. (2023). SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731. SHILAP Revista de lepidopterología. 4(3). 745–750. 2 indexed citations
5.
Ahmed, Atif, Midhat S. Farooqi, Tracy Sandritter, et al.. (2022). Novel OncogenicPDGFRBVariant in Severe Infantile Myofibromatosis With Response to Imatinib Using Therapeutic Drug Monitoring. JCO Precision Oncology. 6(6). e2200250–e2200250. 2 indexed citations
6.
Jayaweera, Dushyantha, Patrick A. Flume, Nora G. Singer, et al.. (2021). Prioritizing studies of COVID-19 and lessons learned. SHILAP Revista de lepidopterología. 5(1). e106–e106. 8 indexed citations
7.
Thompson, Joel, et al.. (2017). Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice. Atherosclerosis. 268. 68–75. 7 indexed citations
8.
Wilson, Patricia G., et al.. (2017). Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition. Journal of Lipid Research. 58(12). 2264–2274. 17 indexed citations
9.
Thompson, Joel, Patricia G. Wilson, Preetha Shridas, et al.. (2017). Serum amyloid A3 is pro-atherogenic. Atherosclerosis. 268. 32–35. 61 indexed citations
10.
Thompson, Joel, Gary Woods, Michael Arnold, et al.. (2016). Pediatric Oral/Maxillofacial Soft Tissue Sarcomas: A Clinicopathologic Report of Four Cases. Case Reports in Oncology. 9(2). 447–453.
11.
Thompson, Joel, et al.. (2014). A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. Journal of Lipid Research. 56(2). 286–293. 80 indexed citations
12.
Tang, Tao, Joel Thompson, Patricia G. Wilson, et al.. (2014). Biglycan deficiency: Increased aortic aneurysm formation and lack of atheroprotection. Journal of Molecular and Cellular Cardiology. 75. 174–180. 22 indexed citations
13.
Thompson, Joel, et al.. (2014). Increased atherosclerosis in mice with increased vascular biglycan content. Atherosclerosis. 235(1). 71–75. 37 indexed citations
14.
Tang, Tao, et al.. (2013). Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr−/− mice. Journal of Lipid Research. 54(8). 2255–2264. 19 indexed citations
15.
Tang, Tao, Joel Thompson, Patricia G. Wilson, et al.. (2012). Decreased Body Fat, Elevated Plasma Transforming Growth Factor-β Levels, and Impaired BMP4-Like Signaling in Biglycan-Deficient Mice. Connective Tissue Research. 54(1). 5–13. 10 indexed citations
16.
Thompson, Joel, et al.. (2011). Renal Accumulation of Biglycan and Lipid Retention Accelerates Diabetic Nephropathy. American Journal Of Pathology. 179(3). 1179–1187. 46 indexed citations
17.
King, Victoria, Joel Thompson, & Lisa R. Tannock. (2011). Serum amyloid A in atherosclerosis. Current Opinion in Lipidology. 22(4). 302–307. 90 indexed citations
18.
Thompson, Joel, et al.. (2010). Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice. Journal of Lipid Research. 51(6). 1464–1470. 14 indexed citations
19.
Wilson, Patricia G., Joel Thompson, Nancy R. Webb, et al.. (2008). Serum Amyloid A, but Not C-Reactive Protein, Stimulates Vascular Proteoglycan Synthesis in a Pro-Atherogenic Manner. American Journal Of Pathology. 173(6). 1902–1910. 59 indexed citations
20.
Huang, Fei, Joel Thompson, Patricia G. Wilson, et al.. (2007). Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. Journal of Lipid Research. 49(3). 521–530. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyuki Kaneto Breakdown of academic impact, for papers by Karen Bulmer Breakdown of academic impact, for papers by Dorella Del Prete Breakdown of academic impact, for papers by Maria Kolatsi‐Joannou Breakdown of academic impact, for papers by Hiroshi Osawa Breakdown of academic impact, for papers by Jun Morinaga Breakdown of academic impact, for papers by Kumiko Torisu Breakdown of academic impact, for papers by Xue Hong Breakdown of academic impact, for papers by Yuji Aoki Breakdown of academic impact, for papers by Samuel Mon-Wei Yu
Rankless by CCL
2026